199 related articles for article (PubMed ID: 35639146)
1. The value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients.
Meng D; Liang C; Zheng Y; Wang X; Liu K; Lin Z; Zhu Q; Zhao X
Eur Radiol; 2022 Dec; 32(12):8608-8616. PubMed ID: 35639146
[TBL] [Abstract][Full Text] [Related]
2. Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
Cai S; Lin X; Sun Y; Lin Z; Wang X; Lin N; Zhao X
Eur J Radiol; 2022 Sep; 154():110449. PubMed ID: 35901599
[TBL] [Abstract][Full Text] [Related]
3. Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
Liu C; Shen Z; Ma H; Wang X; Wang X; Liu K; Wang X; Zhu Q; Zhao X
Eur Radiol; 2022 May; 32(5):3006-3015. PubMed ID: 34989839
[TBL] [Abstract][Full Text] [Related]
4. Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis.
Liu C; Sun Y; Yang Y; Feng Y; Xie X; Qi L; Liu K; Wang X; Zhu Q; Zhao X
Eur Radiol; 2021 Aug; 31(8):5840-5850. PubMed ID: 33533990
[TBL] [Abstract][Full Text] [Related]
5. Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study.
Ding F; Huang M; Ren P; Zhang J; Lin Z; Sun Y; Liang C; Zhao X
Eur Radiol; 2024 Apr; 34(4):2445-2456. PubMed ID: 37691080
[TBL] [Abstract][Full Text] [Related]
6. Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion.
Tsujita Y; Sofue K; Komatsu S; Yamaguchi T; Ueshima E; Ueno Y; Kanda T; Okada T; Nogami M; Yamaguchi M; Tsurusaki M; Hori M; Fukumoto T; Murakami T
Eur J Radiol; 2020 Sep; 130():109189. PubMed ID: 32784077
[TBL] [Abstract][Full Text] [Related]
7. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
8. A nomogram for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma based on spleen-volume-to-platelet ratio.
Meng XQ; Miao H; Xia Y; Shen H; Qian Y; YanChen ; Shen F; Guo J
Asian J Surg; 2023 Jan; 46(1):399-404. PubMed ID: 35599113
[TBL] [Abstract][Full Text] [Related]
9. Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment.
Araki K; Harimoto N; Kubo N; Watanabe A; Igarashi T; Tsukagoshi M; Ishii N; Tsushima Y; Shirabe K
HPB (Oxford); 2020 Feb; 22(2):318-327. PubMed ID: 31477460
[TBL] [Abstract][Full Text] [Related]
10. Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection.
Bae JS; Lee DH; Yoo J; Yi NJ; Lee KW; Suh KS; Kim H; Lee KB
Eur Radiol; 2021 Apr; 31(4):2461-2471. PubMed ID: 33026503
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test.
Kim DK; Choi JI; Choi MH; Park MY; Lee YJ; Rha SE; Jung SE
AJR Am J Roentgenol; 2018 Sep; 211(3):580-587. PubMed ID: 29995498
[TBL] [Abstract][Full Text] [Related]
12. Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma.
Peng W; Zhang XY; Li C; Wen TF; Yan LN; Yang JY
Medicine (Baltimore); 2019 May; 98(18):e15458. PubMed ID: 31045820
[TBL] [Abstract][Full Text] [Related]
13. Prediction of post-hepatectomy liver failure and long-term prognosis after curative resection of hepatocellular carcinoma using liver stiffness measurement.
Chen X; Kuang M; Hu ZH; Peng YH; Wang N; Luo H; Yang P
Arab J Gastroenterol; 2022 May; 23(2):82-88. PubMed ID: 35120839
[TBL] [Abstract][Full Text] [Related]
14. Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram.
Long H; Peng C; Ding H; Zheng Y; Zhou J; Chen W; Zhong X; Shi Y; Duan Y; Xie X; Kuang M; Xie X; Lin M
Eur Radiol; 2023 Nov; 33(11):7665-7674. PubMed ID: 37314474
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular uptake index obtained with gadoxetate disodium-enhanced magnetic resonance imaging in the assessment future liver remnant function after major hepatectomy for biliary malignancy.
Notake T; Shimizu A; Kubota K; Ikehara T; Hayashi H; Yasukawa K; Kobayashi A; Yamada A; Fujinaga Y; Soejima Y
BJS Open; 2021 Jul; 5(4):. PubMed ID: 34254117
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of preoperative shear wave dispersion for prediction of post liver failure in patients with hepatocellular carcinoma after hepatectomy.
Wang K; Zhu Y; Bao J; Zhu Z; Dong Y; Han H; Wang W
Clin Hemorheol Microcirc; 2023; 85(3):223-234. PubMed ID: 36872770
[TBL] [Abstract][Full Text] [Related]
17. Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
Cho HJ; Ahn YH; Sim MS; Eun JW; Kim SS; Kim BW; Huh J; Lee JH; Kim JK; Lee B; Cheong JY; Kim B
Gut Liver; 2022 Mar; 16(2):277-289. PubMed ID: 34810297
[TBL] [Abstract][Full Text] [Related]
18. An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy.
Prodeau M; Drumez E; Duhamel A; Vibert E; Farges O; Lassailly G; Mabrut JY; Hardwigsen J; Régimbeau JM; Soubrane O; Adam R; Pruvot FR; Boleslawski E
J Hepatol; 2019 Nov; 71(5):920-929. PubMed ID: 31203152
[TBL] [Abstract][Full Text] [Related]
19. An mALBI-Child-Pugh-based nomogram for predicting post-hepatectomy liver failure grade B-C in patients with huge hepatocellular carcinoma: a multi-institutional study.
Xu MH; Xu B; Zhou CH; Xue Z; Chen ZS; Xu WX; Huang C; Zhu XD; Zhou J; Fan J; Sun HC; Shen YH
World J Surg Oncol; 2022 Jun; 20(1):206. PubMed ID: 35710377
[TBL] [Abstract][Full Text] [Related]
20. ALBI score combined with FIB-4 index to predict post-hepatectomy liver failure in patients with hepatocellular carcinoma.
Tian YB; Niu H; Xu F; Shang-Guan PW; Song WW
Sci Rep; 2024 Apr; 14(1):8034. PubMed ID: 38580647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
